|
SFRS18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.574800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.530600E-01 |
| Normal-vs-Stage2 |
5.524600E-01 |
| Normal-vs-Stage3 |
1.662980E-01 |
| Normal-vs-Stage4 |
9.157600E-01 |
| Stage1-vs-Stage2 |
6.968800E-01 |
| Stage1-vs-Stage3 |
3.150500E-02 |
| Stage1-vs-Stage4 |
8.982200E-01 |
| Stage2-vs-Stage3 |
1.819830E-01 |
| Stage2-vs-Stage4 |
7.777000E-01 |
| Stage3-vs-Stage4 |
5.178800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.521200E-01 |
| Normal-vs-AfricanAmerican |
4.574400E-01 |
| Normal-vs-Asian |
3.917600E-01 |
| Caucasian-vs-AfricanAmerican |
8.477000E-01 |
| Caucasian-vs-Asian |
3.860400E-01 |
| AfricanAmerican-vs-Asian |
3.731600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.582400E-01 |
| Normal-vs-Female |
5.917800E-01 |
| Male-vs-Female |
9.410600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.083200E-01 |
| Normal-vs-Extreme_Weight |
9.375600E-01 |
| Normal-vs-Obese |
4.233600E-01 |
| Normal-vs-Extreme_Obese |
6.075200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.257400E-01 |
| Normal_Weight-vs-Obese |
8.823600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.633000E-01 |
| Extreme_Weight-vs-Obese |
4.481600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.215000E-01 |
| Obese-vs-Extreme_Obese |
9.661200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.669600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.739800E-02 |
| Normal-vs-Age(61-80Yrs) |
9.528600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.647800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.930200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.998000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.683820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.501600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.761800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.389800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.814000E-02 |
| Normal-VS-Type2 PRCC |
1.149790E-02 |
| Normal-VS-KIRP CIMP |
1.451010E-01 |
| Normal-VS-Unclassified PRCC |
9.940600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.58790000540188E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.877390E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.758400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.800400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.452230E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.280600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.604200E-01 |
| Normal-vs-N1 |
8.808400E-01 |
| Normal-vs-N2 |
3.960100E-02 |
| N0-vs-N1 |
3.789800E-01 |
| N0-vs-N2 |
1.632620E-01 |
| N1-vs-N2 |
1.531360E-01 |
|
|
